BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30305005)

  • 1. Brain Structural and Amyloid Correlates of Recovery From Semantic Interference in Cognitively Normal Individuals With or Without Family History of Late-Onset Alzheimer's Disease.
    Abulafia C; Loewenstein D; Curiel-Cid R; Duarte-Abritta B; Sánchez SM; Vigo DE; Castro MN; Drucaroff LJ; Vázquez S; Sevlever G; Nemeroff CB; Guinjoan SM; Villarreal MF
    J Neuropsychiatry Clin Neurosci; 2019; 31(1):25-36. PubMed ID: 30305005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure to Recover from Proactive Semantic Interference and Abnormal Limbic Connectivity in Asymptomatic, Middle-Aged Offspring of Patients with Late-Onset Alzheimer's Disease.
    Sánchez SM; Abulafia C; Duarte-Abritta B; de Guevara MSL; Castro MN; Drucaroff L; Sevlever G; Nemeroff CB; Vigo DE; Loewenstein DA; Villarreal MF; Guinjoan SM
    J Alzheimers Dis; 2017; 60(3):1183-1193. PubMed ID: 28984601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semantic intrusion errors as a function of age, amyloid, and volumetric loss: a confirmatory path analysis.
    Zheng DD; Curiel Cid RE; Duara R; Kitaigorodsky M; Crocco E; Loewenstein DA
    Int Psychogeriatr; 2022 Nov; 34(11):991-1001. PubMed ID: 33455613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semantic Intrusions and Failure to Recover From Semantic Interference in Mild Cognitive Impairment: Relationship to Amyloid and Cortical Thickness.
    Curiel RE; Loewenstein DA; Rosselli M; Penate A; Greig-Custo MT; Bauer RM; Guinjoan SM; Hanson KS; Li C; Lizarraga G; Barker WW; Torres V; DeKosky S; Adjouadi M; Duara R
    Curr Alzheimer Res; 2018; 15(9):848-855. PubMed ID: 29701153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recovery from Proactive Semantic Interference in Mild Cognitive Impairment and Normal Aging: Relationship to Atrophy in Brain Regions Vulnerable to Alzheimer's Disease.
    Loewenstein DA; Curiel RE; Wright C; Sun X; Alperin N; Crocco E; Czaja SJ; Raffo A; Penate A; Melo J; Capp K; Gamez M; Duara R
    J Alzheimers Dis; 2017; 56(3):1119-1126. PubMed ID: 28106554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Cognitive Stress Test for the Detection of Preclinical Alzheimer Disease: Discriminative Properties and Relation to Amyloid Load.
    Loewenstein DA; Curiel RE; Greig MT; Bauer RM; Rosado M; Bowers D; Wicklund M; Crocco E; Pontecorvo M; Joshi AD; Rodriguez R; Barker WW; Hidalgo J; Duara R
    Am J Geriatr Psychiatry; 2016 Oct; 24(10):804-13. PubMed ID: 27160985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease.
    Oh H; Madison C; Baker S; Rabinovici G; Jagust W
    Brain; 2016 Aug; 139(Pt 8):2275-89. PubMed ID: 27190008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.
    Villain N; Chételat G; Grassiot B; Bourgeat P; Jones G; Ellis KA; Ames D; Martins RN; Eustache F; Salvado O; Masters CL; Rowe CC; Villemagne VL;
    Brain; 2012 Jul; 135(Pt 7):2126-39. PubMed ID: 22628162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recovery from Proactive Semantic Interference and MRI Volume: A Replication and Extension Study.
    Loewenstein DA; Curiel RE; DeKosky S; Rosselli M; Bauer R; Grieg-Custo M; Penate A; Li C; Lizagarra G; Golde T; Adjouadi M; Duara R
    J Alzheimers Dis; 2017; 59(1):131-139. PubMed ID: 28598850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
    Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
    Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortical thickness, brain metabolic activity, and in vivo amyloid deposition in asymptomatic, middle-aged offspring of patients with late-onset Alzheimer's disease.
    Duarte-Abritta B; Villarreal MF; Abulafia C; Loewenstein D; Curiel Cid RE; Castro MN; Surace E; Sánchez SM; Vigo DE; Vázquez S; Nemeroff CB; Sevlever G; Guinjoan SM
    J Psychiatr Res; 2018 Dec; 107():11-18. PubMed ID: 30308328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of Cortical and Subcortical Amyloid Burden across Stages of Preclinical Alzheimer's Disease.
    Edmonds EC; Bangen KJ; Delano-Wood L; Nation DA; Furst AJ; Salmon DP; Bondi MW;
    J Int Neuropsychol Soc; 2016 Nov; 22(10):978-990. PubMed ID: 27903335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease.
    Kreisl WC; Lyoo CH; McGwier M; Snow J; Jenko KJ; Kimura N; Corona W; Morse CL; Zoghbi SS; Pike VW; McMahon FJ; Turner RS; Innis RB;
    Brain; 2013 Jul; 136(Pt 7):2228-38. PubMed ID: 23775979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electromagnetic signatures of the preclinical and prodromal stages of Alzheimer's disease.
    Nakamura A; Cuesta P; Fernández A; Arahata Y; Iwata K; Kuratsubo I; Bundo M; Hattori H; Sakurai T; Fukuda K; Washimi Y; Endo H; Takeda A; Diers K; Bajo R; Maestú F; Ito K; Kato T
    Brain; 2018 May; 141(5):1470-1485. PubMed ID: 29522156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel cognitive assessment paradigm to detect Pre-mild cognitive impairment (PreMCI) and the relationship to biological markers of Alzheimer's disease.
    Crocco EA; Loewenstein DA; Curiel RE; Alperin N; Czaja SJ; Harvey PD; Sun X; Lenchus J; Raffo A; Peñate A; Melo J; Sang L; Valdivia R; Cardenas K
    J Psychiatr Res; 2018 Jan; 96():33-38. PubMed ID: 28957712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilizing semantic intrusions to identify amyloid positivity in mild cognitive impairment.
    Loewenstein DA; Curiel RE; DeKosky S; Bauer RM; Rosselli M; Guinjoan SM; Adjouadi M; Peñate A; Barker WW; Goenaga S; Golde T; Greig-Custo MT; Hanson KS; Li C; Lizarraga G; Marsiske M; Duara R
    Neurology; 2018 Sep; 91(10):e976-e984. PubMed ID: 30076274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Education on Alzheimer's Disease-Related Neuroimaging Biomarkers in Healthy Controls, and Participants with Mild Cognitive Impairment and Alzheimer's Disease: A Cross-Sectional Study.
    Wada M; Noda Y; Shinagawa S; Chung JK; Sawada K; Ogyu K; Tarumi R; Tsugawa S; Miyazaki T; Yamagata B; Graff-Guerrero A; Mimura M; Nakajima S;
    J Alzheimers Dis; 2018; 63(2):861-869. PubMed ID: 29689728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
    Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
    Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of moderate alcohol intake with in vivo amyloid-beta deposition in human brain: A cross-sectional study.
    Kim JW; Byun MS; Yi D; Lee JH; Ko K; Jeon SY; Sohn BK; Lee JY; Kim YK; Shin SA; Sohn CH; Lee DY;
    PLoS Med; 2020 Feb; 17(2):e1003022. PubMed ID: 32097439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The A4 study: β-amyloid and cognition in 4432 cognitively unimpaired adults.
    Insel PS; Donohue MC; Sperling R; Hansson O; Mattsson-Carlgren N
    Ann Clin Transl Neurol; 2020 May; 7(5):776-785. PubMed ID: 32315118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.